The Horizons Tracker

APRIL 11, 2023

A recent study from Texas A&M University looks at the role innovation potential can play in terms of providing a sufficiently credible signal to reduce the impact insider sales have on perceptions of quality. “Our research, however, documents a positive effect on IPO valuation from informing investors of future innovation plans.

IPO 118

IPO Reference Innovation Pharmaceuticals 118

The Horizons Tracker

OCTOBER 4, 2022

The researchers explain that while firms reap significant benefits from the innovations that often arise from partnering with universities, the fact that academics usually wish to publish their work in academic journals can raise fears that the secret sauce will be exposed to the wider world. ” Fruitful collaboration.

Hedge 114

Hedge Pharmaceuticals Document Innovation 114

The Horizons Tracker

OCTOBER 21, 2021

New research from INSEAD explores this power dynamic in the context of the video game market. The market for PlayStation2 games was chosen because the lack of self-publishing opportunities at the time meant that developers had to partner with publishers to get their games to market. Power play. Securing help.

Entrepreneur 129

Entrepreneur Biotechnology Pharmaceuticals Marketing 129

Lead on Purpose

SEPTEMBER 8, 2009

Over 150 companies, including Durkee, Cremora, San Giorgio, Ronzoni, and McCormick, now use the entire line of Flapper products, and Weatherchem continues to lead the industry in offering the widest, most innovative array of closure products. Filed under: Integrity , Leadership , Purpose , Team Building , Trust Tagged: | Albert J.

Committee 140

Committee Automotive Ethics Products 140

The Horizons Tracker

NOVEMBER 23, 2020

The coronavirus pandemic has thrust the healthcare and pharmaceutical industries into the limelight like never before. It’s a prominence that new research from Novartis suggests has created a fresh allure for the industry in the eyes of the best tech talent on the market. Driving change.

Industry 104

Industry Pharmaceuticals Technology Finance 104

Tanveer Naseer

MARCH 10, 2015

The following is a guest piece by Innovation Excellence co-founder Rowan Gibson. What most companies understand now is that the only way to drive profitable growth and wealth creation over the longer term is to innovate. But that’s not the way radical innovators envisage their organizations. This is quite understandable.

How To 100

How To Retail Core Competence Innovation 100

The Horizons Tracker

SEPTEMBER 21, 2023

New markets The data implies a lively market for CEOs, enticed by the prospect of elevated remuneration, reduced public scrutiny, and the operational proficiency that private equity (PE) firms offer. You’ve got to learn the specifics of the company, but it’s not as hard as you think,” the researchers explain.

Press Release 119

Press Release CEO Pharmaceuticals Industry 119

The Horizons Tracker

SEPTEMBER 15, 2019

model, which is supported by the Estonian government, demonstrates the paths to new business models that focus not only on providing services, but also on fostering a collaborative platform for all to innovate. The E-Residency initiative and its succeeding 2.0

Pharmaceuticals 71

Pharmaceuticals Entrepreneur Politics Globalization 71

Talent Anarchy 1

AUGUST 25, 2023

In today’s ever-evolving job market, individuals are constantly on the lookout for career paths that promise stability, growth, and fulfillment. Pharmaceuticals: Medicines and healthcare products are also considered consumer non-durables. This includes advertising campaigns, social media marketing, and product launches.

Career 60

Career Supply Chain Pharmaceuticals Industry 60

First Friday Book Synopsis

MARCH 21, 2012

An entrepreneur and veteran of the computer industry, Frank Moss spent his career bringing innovative technologies to market. Ten years ago he set out to make a broader contribution to the world, leading him to cofound a cancer drug discovery company and then to the MIT Media Lab, where he served as director from 2006 [.].

Entrepreneur 80

Entrepreneur Media Technology Innovation 80

Strategy Driven

JULY 13, 2011

It turned out that the unit was driving profits by raising prices and cutting marketing and advertising expenditures. Higher prices and reduced advertising created an opening for competitors to take away market share, which they did. So while profits were rising and ROIC was high, market share was declining.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Coaching Tip

MARCH 15, 2011

Nothing has ever been able to keep it down for long, and nothing ever will, if we are patient and allow our economy the time to heal itself through the virtues of the free-market system. . All it takes is the desire to be innovative and creative in tackling a problem. Deregulation. Entrepreneurship.

Pharmaceuticals 84

Pharmaceuticals Creativity Long-term Power 84

The Horizons Tracker

FEBRUARY 22, 2022

It’s a market that is already worth $3.1 billion and is estimated to be worth $48 billion by 2026, with the Covid pandemic driving growth, especially in the healthcare and pharmaceutical industries, but also in sectors such as automotive and defense. “ There are cases with upload speeds of over 1Gbps.

Stephenson 114

Stephenson Wireless Christensen Automotive 114

The Horizons Tracker

SEPTEMBER 10, 2021

By contrast, firms operating in areas such as online retail, pharmaceuticals, and information and communications technology, have all thrived. Smaller firms were especially affected by the virus because they rely far more on face-to-face interactions with customers for both marketing and transactions. Face-to-face interactions.

Pharmaceuticals 58

Pharmaceuticals Transportation Retail Long-term 58

Strategy Driven

JUNE 22, 2018

By adapting your marketing strategy, you will be able to target new audiences for your products and services. Let’s look at the niche markets that you can tap into boost your business’s growth and profitability: Seniors. When marketing for seniors you need to pay great attention to the content that you produce, especially online.

Audience 50

Audience Niche Marketing How To Marketing Strategy 50

Harvard Business Review

JUNE 7, 2012

The numbers are enough to make the apple pop right out of the marketer's eye. Clearly that's not quite the target market for a new washer and dryer. Medical supply and equipment costs are abating under market pressure. Pharmaceutical patent expirations are increasing the use of cheaper generic drugs.

Disruptive Innovation 22

Disruptive Innovation Innovation Pharmaceuticals Class 22

Strategy Driven

JANUARY 24, 2011

Closing the Execution Gap : How Great Leaders and Their Companies Get Results by Richard Lepsinger If an organization can’t execute its plans and initiatives, nothing else matters: not the most solid, well thought-out strategy, not the most innovative business model, not even technological breakthroughs that could transform an industry.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Strategy Driven

MARCH 18, 2011

In The Essential Advantage : How to Win with a Capabilities-Driven Strategy , Booz & Company’s Paul Leinwand and Cesare Mainardi maintain that success in any market accrues to firms with a coherence premium – a tight match between their strategic direction and the capabilities that make them unique. Let’s go after it.”

Resources 51

Resources Industry System Strategy 51

Harvard Business Review

SEPTEMBER 15, 2011

What they found is that America's patent system only provides positive incentives for innovation in two industries: pharmaceuticals and chemicals. Anyone innovating outside of those two industries would be better off if there were no patent system at all.

Innovation 15

Innovation Chemicals Incentives Pharmaceuticals 15

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Dr Reddy's plan is to leverage Chirotech's scientific capabilities to optimize drug development processes, thus lowering manufacturing costs and speeding time-to-market. Cambridge, U.K. facility in Cambridge Science Park.

Globalization 14

Globalization Innovation Decentralization Chemicals 14

Harvard Business Review

JULY 8, 2016

The difference between displacement (outperforming existing market incumbents at their own game) and disruption (changing the game) is strategically important, no matter how similar the pain they cause is. Displacement generally is easier to combat than disruption. This presents Western companies with a fresh challenge.

Business Model 14

Business Model Innovation Company Apparel 14

Harvard Business Review

SEPTEMBER 23, 2014

I often hear this question when I visit companies and speak about how to make an innovative idea less terrifying to high level executives. There are plenty of pundits arguing that big companies need to innovate, and pointing out that it is difficult to do so. Have you actually seen this done?”. The skepticism is warranted.

Innovation 14

Innovation P&L Short-term Company 14

Harvard Business Review

MARCH 28, 2012

The Swiss pharmaceutical giant Roche is nothing if not determined in its quest to acquire Illumina, the San Diego-based leader in genetic-sequencing equipment. An acquirer looking for innovation would have been likelier to try to buy Gateway, a company that is almost an after-thought now. billion tender offer directly to shareholders.

Innovation 15

Innovation Company Biotechnology CFO 15

Harvard Business Review

MARCH 11, 2018

That rule of life is no secret to pharmaceutical companies across the globe. Japan remains the world’s second-biggest pharmaceuticals market, behind only the United States and China. The Japanese market also is expected to grow annually. Older people need more medicine. Read More from the Government of Japan.

Pharmaceuticals 9

Pharmaceuticals Health Care Industry Content 9

Harvard Business Review

FEBRUARY 16, 2017

Most businesses wouldn’t survive without driving demand for their products or services, either through marketing and advertising or through involving users so deeply in the design of the product that word of mouth spurs adoption. The same is true for social innovators. But even the most needed innovation does not sell itself.

Innovation 13

Innovation Rogers NGO Participative 13

Harvard Business Review

OCTOBER 11, 2013

Four years ago, Craig Hatkoff, co-founder of the Tribeca Film Festival, approached me about a brainstorm: an event recognizing and celebrating breakthrough innovators. When I suggested to Clayton Christensen that we partner with Hatkoff to create the Tribeca Disruptive Innovation Awards , Clay’s response was : I trust you Whitney.

Innovation 14

Innovation Christensen Decisionmaking CTO 14

Harvard Business Review

JUNE 7, 2012

The numbers are enough to make the apple pop right out of the marketer's eye. Clearly that's not quite the target market for a new washer and dryer. Medical supply and equipment costs are abating under market pressure. Pharmaceutical patent expirations are increasing the use of cheaper generic drugs.

Disruptive Innovation 15

Disruptive Innovation Innovation Pharmaceuticals Class 15

Harvard Business Review

OCTOBER 29, 2012

If the cost of innovation is falling, that should enable more of it from poorer countries, companies or cooperatives. If it's not, the already big and already rich will dominate innovation. Some of this may just be the product of the high regulatory costs in pharmaceuticals, but research by Harvard's F.M.

Cost 10

Cost Innovation Wireless Disruptive Innovation 10

Harvard Business Review

AUGUST 9, 2012

Selling pharmaceuticals in Latin America is not the same as selling them in the United States or Western Europe. Second, in most Latin American countries, pharmaceutical companies are not allowed to advertise directly to consumers. Right off the bat, I can identify four big differences. They were correct.

Pharmaceuticals 15

Pharmaceuticals Strategy Advertising Price 15

Harvard Business Review

AUGUST 3, 2016

That can benefit consumers through lower prices, more innovation, and better products. On the other hand, M&As can also strengthen the market power of the combined entity, reducing competition in a way that harms consumers. Research has shown that pharma mergers reduce innovation. What’s the reason for this?

Innovation 8

Innovation Pharmaceuticals Company Price 8

Harvard Business Review

SEPTEMBER 12, 2012

The study assembles considerable evidence about the hidden business model of major pharmaceutical companies: to devote most of their research budget to developing hundreds of drugs that provide few if any advantages over existing drugs and then market them heavily to doctors and patients. But why not?

Business Model 15

Business Model Company Pharmaceuticals Price 15

Harvard Business Review

MARCH 8, 2011

Editor's note: This post is part of a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. For example, Sproxil has found pharmaceutical buyers for its anti-drug counterfeiting service. There are now more than 5.3

Wireless 16

Wireless Health Care Pharmaceuticals Business Model 16

Harvard Business Review

MAY 20, 2014

financial services sector went from 13,000 of independent banks to half that number, while the top ten banks grew from 20% market share to 60%. As of 2013, the top ten banks had 70% of the market. In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. In the guitar business , too.

Pharmaceuticals 14

Pharmaceuticals Banking Chemicals Entrepreneur 14

Harvard Business Review

SEPTEMBER 4, 2015

Innovation is widely regarded as important to long-term business performance. We’ve found that CEOs of big pharmaceutical companies, for example, are more likely to have a background as company lawyers, salespeople, or finance managers, than one in medicine or pharmaceutical R&D. Overall, it is a messy picture.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

MAY 26, 2016

While a dynamic, competitive economy rewards innovative firms with high profits and punishes poor performers with low profits, sustained aggregate profits suggest, instead, that firms are able to get away with higher prices because competition is limited. If so, then high profits portend diminished productivity growth.

Pharmaceuticals 14

Pharmaceuticals Politics Price Chemicals 14

Harvard Business Review

JUNE 16, 2011

So it is with most breakthrough innovations and banner financial years. Investors grapple daily in an effort to figure out how to value companies whose accounting assets — things like land, capital, products, and licenses — don't adequately express their true market value. If ego and time allow, the list can be quite long.

Intangible Assets 16

Intangible Assets Analysis Pharmaceuticals Innovation 16

Harvard Business Review

OCTOBER 6, 2016

Barbara Kellerman from Harvard, Jeffrey Pfeffer from Stanford, and numerous other experts have pointed out that the development market is filled with fads — slick behavioral models and fun, engaging tools — that don’t really move the needle. The culture at GE, for example, centers on execution, simplicity, and innovation.

Leadership Pipeline 16

Leadership Pipeline Leadership After Action Review Pharmaceuticals 16